Psychemedics

Psychemedics ROCE

The Return on Capital Employed (ROCE) of Psychemedics (PMDI) as of Oct 18, 2026 is -36.90 %. In the previous year, Return on Capital Employed (ROCE) was -43.78 % — a change of -15.71% (higher).

ROCE

-36.90 %

YoY

-15.71%

Last updated:

In 2024, Psychemedics's return on capital employed (ROCE) was -36.90 %, a -15.71% increase from the -43.78 % ROCE in the previous year.

The Psychemedics ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2017
43.82 USD
Jan 1, 2018
40.61 USD
Jan 1, 2019
17.84 USD
Jan 1, 2020
-48.48 USD
Jan 1, 2021
1.71 USD
Jan 1, 2022
-10.05 USD
Jan 1, 2023
-43.78 USD
Jan 1, 2024
-36.90 USD
The Psychemedics ROCE history
YEARROCEYoY
-36.90 %-15.71%
-43.78 %+335.41%
-10.05 %-689.00%
1.71 %-103.52%
-48.48 %-371.82%
17.84 %-56.08%
40.61 %-7.34%
43.82 %-32.38%
64.81 %+414.93%
12.59 %-65.54%
36.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp, trading under the ticker PMDI, is a U.S.-based company headquartered in Acton, Massachusetts. The company specializes in drug testing services, focusing on the analysis of hair samples to detect the presence of drugs of abuse. With 204 full-time employees, Psychemedics operates within the Health Care sector, specifically in the Health Care industry. The company's primary service involves conducting drug tests and reporting results to clients, including training for sample collection and storage of positive samples for a fee per unit tested. Its testing methodology provides detailed information on the approximate amount of drug ingested and historical data on drug use patterns over time. Psychemedics went public on January 22, 1987, marking the beginning of its journey as a publicly traded entity. The company's website, https://www.psychemedics.com/, serves as a primary source of information for its services and operations. While the company's core business is centered on drug testing, it does not disclose specific product names or additional services beyond the scope of hair sample analysis and reporting. Psychemedics maintains a presence in the U.S. market, with its operations primarily focused on providing reliable and detailed drug testing solutions to its clients. The company's approach to testing emphasizes both the immediate detection of drug use and the ability to track usage patterns over extended periods, offering a comprehensive service for its customers. Psychemedics is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Psychemedics's Return on Capital Employed (ROCE)

Psychemedics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Psychemedics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Psychemedics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Psychemedics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Psychemedics stock

Return on Capital Employed (ROCE) of Psychemedics is -36.90 % in 2024.

Return on Capital Employed (ROCE) of Psychemedics changed from -43.78 % to -36.90 %, representing a -15.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Psychemedics since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Psychemedics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Psychemedics

All Key Metrics — Psychemedics